The Functions of the RNA Polymerase II CTD in Transcription and RNA Processing

Total Page:16

File Type:pdf, Size:1020Kb

The Functions of the RNA Polymerase II CTD in Transcription and RNA Processing The functions of the RNA polymerase II CTD in transcription and RNA processing Jing-Ping Hsin Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2013 © 2013 Jing-Ping Hsin All rights reserved Abstract The functions of the RNA polymerase II CTD in transcription and RNA processing Jing-Ping Hsin RNA polymerase II (RNAP II), transcribing messenger RNAs (mRNAs), small nuclear RNAs (snRNAs), and non-coding RNAs (ncRNAs), is composed of 12 subunits. Rpb1, the largest subunit with catalytic polymerase activity, possesses a unique c-terminal domain (CTD) that consists of tandem heptad repeats with the consensus sequence of Tyr-Ser-Pro-Thr-Ser-Pro-Ser (Y1S2P3T4S5P6S7). Somewhat reflecting the complexity of the organism, the number of repeats varies, from 26 in yeast to 52 in vertebrates. The CTD, intensively phosphorylated during transcription, serves a means to coordinate transcription and RNA processing- capping, splicing, and 3’ end formation. For example, Ser 5, phosphorylated in the start of transcription, promotes the recruitment of capping enzyme, and Ser 2 phosphorylation facilitates RNA 3’ end formation and transcription termination by acting as a landing pad for Pcf11. Detailed introduction is described in Chapter 1. Because of the importance of the CTD in these events, I created an Rpb1 conditional knock-out DT40 cell line (DT40-Rpb1) to further study the CTD with an initial focus on Thr 4, the function of which was unclear. Using DT40-Rpb1 system, we found that Thr 4 was phosphorylated in yeast, fly, chicken, and human cells, and cyclin-dependent kinase (CDK9) was likely the kinase to carry out this phosphorylation. We further provide evidence that Thr 4 functions in histone mRNA 3’ end formation (presented mostly in chapter 2 of this thesis). Chapter 3 mainly describes the studies regarding Ser 2, Ser 5, and Ser 7. Based on the DT40-Rpb1 cell line, I created stable cell lines expressing an Rpb1 carrying a CTD with Ser 2, Ser 5, or Ser 7 mutated to alanine, and investigated the phenotypes of these cells. We found that cells expressing an Rpb1 with S2A or S5A mutation were defective in transcription and RNA processing. Contrary to previous findings, we found Ser 7 was not involved in snRNA expression and 3’ end processing. In fact, no phenotypes associated with Ser 7 mutation were detected by our measurements. Extending previous Thr 4 studies, we showed in vitro and in vivo that Fcp1 dephosphorylated Thr 4. Finally, Chapter 4 describes what we have found the functions of CTD Tyr 1. Using the DT40-Rpb1 cells, I created stable cell lines expressing an Rpb1 with all Tyr residues mutated to phenylalanine (Phe). We found these cells were inviable, and the mutant Rpb1-Y1F was degraded to a CTD-less protein. Interestingly, the instability of Rpb1-Y1F was restored by reintroduction of one Tyr residue at the last heptad repeat. Further analysis provided evidence showing the involvement of Tyr phosphorylation in preventing Rpb1 from degradation by the 20S proteasome. Next, using ChIP assay, we showed Tyr phosphorylation was detected mostly at promoters, indicating a function of Tyr phosphorylation in transcription initiation. Indeed, transcription initiation defects were uncovered by assessing the recruitment of general transcription factors in cells with Y1F mutation. Extending this, we found an accumulation of upstream antisense RNAs in about one hundred reference genes by RNA-Seq analysis. TABLE OF CONTENTS Acknowledgements iv Dedication v Preface vi Chapter 1 The RNA polymerase II CTD coordinates transcription and RNA processing ………………………..….………… 1 Abstract ………………………………………………………………………………………………………………………………….…………… 2 Introduction ………………………………………………………………………………………………………………………….…………….. 2 CTD architecture and modification …………………………………………………………………………………….………………… 4 Transcription elongation, chromatin, and the CTD ……………………………………………………………………………… 13 RNA processing and the CTD ………………………………………………………………………………………………………………. 16 The CTD and transcription termination …………………………………………………………………………………………...…. 25 Perspectives …………………………………………………………………………………………………………………………………..…... 28 Acknowledgments ………………………………………………………………………………………………………………………………. 29 References ………………………………………………………………………………………………………………………………………….. 30 Figure legends …………………………………………………………………………………………………………………………………….. 48 Table …………………………………………………………………………………………………………………………………………………… 51 Figures …………………………………………………………………………………………………………………………………….……....... 53 Chapter 2 RNAP II CTD phosphorylated on threonine 4 is required for histone mRNA 3’ end processing ………... 58 i Abstract …………………………………………………………………………………………………………………………………………..… 59 Introduction …………………………………………………………………………………………………………………………………….… 60 Results ………………………………………………………………………………………………………………………………………………. 60 References and notes ………………………………………………………………………………………………………………………… 64 Acknowledgment ………………………………………………………………………………………………………………………………. 65 Figure legends …………………………………………………………………………………………………………………………………… 65 Figures …………………………………………………………………………………………………………………………………………….… 68 Supplemental materials ……………………………………………………………………………………………………………….……. 72 Chapter 3 Function and control of RNA polymerase II CTD in vertebrate transcription and RNA processing …… 91 Abstract …………………………………………………………………………………………………………………………………………..… 92 Introduction ……………………………………………………………………………………………………………………………………... 93 Results ………………………………………………………………………………………………………………………………………………. 96 Discussion …………………………………………………………………………………………………………………………………………. 102 Acknowledgment …………………………………………………………………………………………………………………..…….…… 107 Materials and methods …………………………………………………………………………………………………………………….. 107 References ……………………………………………………………………………………………………………………………………….. 110 Figure legends ………………………………………………………………………………………………………………………………….. 114 Table 1 ……………………………………………………………………………………………………………………………………………... 118 Supplemental figure legends …………………………………………………………………………………………..……………….. 118 Figures …………………………………………………………………………………………………………………………….……………….. 120 ii Supplemental figures ……………………………………………………………………………………………………………………….. 125 Chapter 4 Functional analysis of RNAP II CTD tyrosine 1 …………………………………………………………..…………………… 130 Abstract …………………………………………………………………………………………………………………..…………..………..… 131 Introduction …………………………………………………………………………………………………………..………………………... 132 Results …………………………………………………………………………………………………………………..…………………………. 135 Discussion …………………………………………………………………………………………………………………………………………. 143 Materials and methods …………………………………………………………………………………………………………………….. 148 Acknowledgment …………………………………………………………………………………………………………………..…….…… 151 References ……………………………………………………………………………………………………………………………………….. 151 Figure legends ………………………………………………………………………………………………………………………………….. 156 Supplemental figure legends …………………………………………………………………………………………..……………….. 159 Figures ……………………………………………………………………………………………………………………………………………… 161 Supplemental figures …………………………………………………………………………………………………………….…………. 167 iii Acknowledgements I would like first to thank my thesis research advisor, Jim Manley, for support over these years. From working in his lab, I have learned a great deal: how to write papers, defend ideas in the papers, and present data. I also like to thank my thesis committee members Larry Chasin and Carol Prives for support and many useful suggestions, and my other committee members, Liang Tong, Robert Fisher, and Stewart Shuman for taking the time to be on my thesis defense committee. I enjoy very much working in our very diverse lab with members of different backgrounds and ways of thinking. In the beginning of my project, I worked closely with Tsuyoshi Kashima, who taught me how to build the Rpb1 conditional knock-out cells. To him, I owe many thanks. I am thankful that I often get useful ideas through discussions with many lab members, especially Patricia Richard, Kehui Xiang, Ying Feng, Dafne Campigli Di Giammartino, Chuck David, and Emanuel Rosonina. I am grateful that Patricia, Chong Han Ng, Dafne, Tristan Coady, and Emanuel rehearsed many talks with me. Other lab members have been helpful in many ways- the assistance from Amit Sheth, Alex Boyne often voluntarily watching the levels of my running buffer, and etc. My family has been very supportive in this PhD journey. I appreciate vey much the encouragement they gave me when I was struggling with my research project. iv Dedication To my family v Preface This thesis is divided into four chapters. Chapter 1 is an introduction to the functions of the CTD of RNA polymerase II, and has been published as a review article in Genes and Development. Chapter 2 is a research article entitled “RNAP II CTD phosphorylated on threonine 4 is required for histone mRNA 3’ end processing,” published in Science. Chapter 3 is a manuscript with a title “Function and control of RNA polymerase II CTD phosphorylation in vertebrate transcription and RNA processing” that has been submitted for publication. Chapter 4 is the draft of a manuscript in preparation for publication. vi 1 Chapter 1 The RNA polymerase II CTD coordinates transcription and RNA processing Jing-Ping Hsin and James L. Manley Department of Biological Sciences Columbia University New York, NY 10027, USA 2 Abstract The carboxy terminal domain of the RNA polymerase II largest subunit (CTD) consists of multiple heptad repeats (consensus Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7), varying in number from 26 in yeast to 52 in vertebrates. The CTD functions to help couple transcription
Recommended publications
  • Multiple Cellular Proteins Interact with LEDGF/P75 Through a Conserved Unstructured Consensus Motif
    ARTICLE Received 19 Jan 2015 | Accepted 1 Jul 2015 | Published 6 Aug 2015 DOI: 10.1038/ncomms8968 Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif Petr Tesina1,2,3,*, Katerˇina Cˇerma´kova´4,*, Magdalena Horˇejsˇ´ı3, Katerˇina Procha´zkova´1, Milan Fa´bry3, Subhalakshmi Sharma4, Frauke Christ4, Jonas Demeulemeester4, Zeger Debyser4, Jan De Rijck4,**, Va´clav Veverka1,** & Pavlı´na Rˇeza´cˇova´1,3,** Lens epithelium-derived growth factor (LEDGF/p75) is an epigenetic reader and attractive therapeutic target involved in HIV integration and the development of mixed lineage leukaemia (MLL1) fusion-driven leukaemia. Besides HIV integrase and the MLL1-menin complex, LEDGF/p75 interacts with various cellular proteins via its integrase binding domain (IBD). Here we present structural characterization of IBD interactions with transcriptional repressor JPO2 and domesticated transposase PogZ, and show that the PogZ interaction is nearly identical to the interaction of LEDGF/p75 with MLL1. The interaction with the IBD is maintained by an intrinsically disordered IBD-binding motif (IBM) common to all known cellular partners of LEDGF/p75. In addition, based on IBM conservation, we identify and validate IWS1 as a novel LEDGF/p75 interaction partner. Our results also reveal how HIV integrase efficiently displaces cellular binding partners from LEDGF/p75. Finally, the similar binding modes of LEDGF/p75 interaction partners represent a new challenge for the development of selective interaction inhibitors. 1 Institute of Organic Chemistry and Biochemistry of the ASCR, v.v.i., Flemingovo nam. 2, 166 10 Prague, Czech Republic. 2 Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Vinicna 5, 128 44 Prague, Czech Republic.
    [Show full text]
  • Rho Dependent Termination of Transcription in Prokaryotes
    Rho Dependent Termination Of Transcription In Prokaryotes Organoleptic Tymon scrimshaws no athenaeums yean fleetly after Teodorico whiled tunably, quite scrawliest. Amalgamative and honeyed Ximenes syllables her bullheads picket stork's-bill and debouch visually. Colory Jeffery concentred her avidity so injudiciously that Sergio briquet very injunctively. Dna in prokaryotic polymerase in termination may vary. Dna sequence by enzymes and fall off of transcripts, and marylène bertrand for the conformation of rho in the stalled rna helicases, rho dependent termination of in transcription. The other physiological functions are the basis for rna polymerase and longer as elongation complex forming a series of one of rho termination in transcription factors recognizing promoters in four steps. Eukaryotes require cookies from prokaryotes, depending on a fifth subunit involved. Thus, when translation termination occurs within same gene it the cause transcriptional termination, preventing expression of downstream genes. Atp synthase alpha and therefore be specialized rnas make a bsr, in termination of rho transcription prokaryotes. Dna must accept cookies and also found later in part because of rho termination occurs by the initiation site that bind to understand how they cannot be logged in replicating dna. Concerned about the Coronavirus? It is made rna polymerase causes rna in termination of rho transcription termination mechanisms to specific genes. Depending upon request your changes indicating that prokaryotic rnap with and prokaryotes. The DNA strand within this an is transcribed by the RNA polymerase. The basic promoter region in prokaryotic transcription is referred to two the Pribnow box. Formation of which prokaryotic and on the hfq is shown as the transcript of action of rho dependent termination transcription in prokaryotes have far more about ten base that elongation complex cell components and cell.
    [Show full text]
  • The Function and Evolution of C2H2 Zinc Finger Proteins and Transposons
    The function and evolution of C2H2 zinc finger proteins and transposons by Laura Francesca Campitelli A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Laura Francesca Campitelli 2020 The function and evolution of C2H2 zinc finger proteins and transposons Laura Francesca Campitelli Doctor of Philosophy Department of Molecular Genetics University of Toronto 2020 Abstract Transcription factors (TFs) confer specificity to transcriptional regulation by binding specific DNA sequences and ultimately affecting the ability of RNA polymerase to transcribe a locus. The C2H2 zinc finger proteins (C2H2 ZFPs) are a TF class with the unique ability to diversify their DNA-binding specificities in a short evolutionary time. C2H2 ZFPs comprise the largest class of TFs in Mammalian genomes, including nearly half of all Human TFs (747/1,639). Positive selection on the DNA-binding specificities of C2H2 ZFPs is explained by an evolutionary arms race with endogenous retroelements (EREs; copy-and-paste transposable elements), where the C2H2 ZFPs containing a KRAB repressor domain (KZFPs; 344/747 Human C2H2 ZFPs) are thought to diversify to bind new EREs and repress deleterious transposition events. However, evidence of the gain and loss of KZFP binding sites on the ERE sequence is sparse due to poor resolution of ERE sequence evolution, despite the recent publication of binding preferences for 242/344 Human KZFPs. The goal of my doctoral work has been to characterize the Human C2H2 ZFPs, with specific interest in their evolutionary history, functional diversity, and coevolution with LINE EREs.
    [Show full text]
  • Resistance to Rifampicin: a Review
    The Journal of Antibiotics (2014) 67, 625–630 & 2014 Japan Antibiotics Research Association All rights reserved 0021-8820/14 www.nature.com/ja REVIEW ARTICLE Resistance to rifampicin: a review Beth P Goldstein Resistance to rifampicin (RIF) is a broad subject covering not just the mechanism of clinical resistance, nearly always due to a genetic change in the b subunit of bacterial RNA polymerase (RNAP), but also how studies of resistant polymerases have helped us understand the structure of the enzyme, the intricacies of the transcription process and its role in complex physiological pathways. This review can only scratch the surface of these phenomena. The identification, in strains of Escherichia coli, of the positions within b of the mutations determining resistance is discussed in some detail, as are mutations in organisms that are therapeutic targets of RIF, in particular Mycobacterium tuberculosis. Interestingly, changes in the same three codons of the consensus sequence occur repeatedly in unrelated RIF-resistant (RIFr) clinical isolates of several different bacterial species, and a single mutation predominates in mycobacteria. The utilization of our knowledge of these mutations to develop rapid screening tests for detecting resistance is briefly discussed. Cross-resistance among rifamycins has been a topic of controversy; current thinking is that there is no difference in the susceptibility of RNAP mutants to RIF, rifapentine and rifabutin. Also summarized are intrinsic RIF resistance and other resistance mechanisms. The Journal of Antibiotics (2014) 67, 625–630; doi:10.1038/ja.2014.107; published online 13 August 2014 INTRODUCTION laboratory studies and emerging in patients who received mono- In celebrating the life of Professor Piero Sensi and his discovery of therapy with RIF.
    [Show full text]
  • A Collection of Pre-Mrna Splicing Mutants in Arabidopsis Thaliana
    G3: Genes|Genomes|Genetics Early Online, published on April 7, 2020 as doi:10.1534/g3.119.400998 1 1 A collection of pre-mRNA splicing mutants in Arabidopsis thaliana 2 3 4 Tatsuo Kanno1,a, Peter Venhuizen2,a, Ming-Tsung Wu3, Phebe Chiou1, Chia-Liang Chang1, 5 Maria Kalyna2,c, Antonius J.M. Matzke1,c and Marjori Matzke1,c 6 7 1Institute of Plant and Microbial Biology, Academia Sinica, 128, Sec. 2, Academia Rd., Nangang 8 District, Taipei, 11529 Taiwan 9 10 2Department of Applied Genetics and Cell Biology, University of Natural Resources and Life 11 Sciences - BOKU, Muthgasse 18, 1190 Vienna, Austria 12 13 3Department of Plant Sciences, University of Cambridge, Downing Street, CB2 3EA Cambridge, 14 UK 15 16 athese authors should be regarded as joint first authors 17 18 19 cCorresponding authors: 20 Antonius J.M. Matzke ([email protected]) 21 Tel: +886-2787-1135 22 Marjori Matzke ([email protected]) 23 Tel: +886-2787-1135 24 Maria Kalyna ([email protected]) 25 Tel: +43-1-47654-94112 26 27 28 29 30 31 32 © The Author(s) 2020. Published by the Genetics Society of America. 2 33 34 Running title: Arabidopsis pre-mRNA splicing mutants 35 36 Key words: Arabidopsis thaliana, CBP80. miRNAs, mutant screen, pre-mRNA splicing 37 38 39 40 Corresponding authors: 41 Antonius J.M. Matzke ([email protected]), Institute of Plant and Microbial 42 Biology, Academia Sinica, 128, Sec. 2, Academia Rd., Nangang District, Taipei, 11529 Taiwan 43 Tel: +886-2787-1135 44 45 Marjori Matzke ([email protected]), Institute of Plant and Microbial Biology, 46 Academia Sinica, 128, Sec.
    [Show full text]
  • Bicyclomycin Sensitivity and Resistance Affect Rho Factor-Mediated Transcription Termination in the Tna Operon of Escherichia Coli
    JOURNAL OF BACTERIOLOGY, Aug. 1995, p. 4451–4456 Vol. 177, No. 15 0021-9193/95/$04.0010 Copyright 1995, American Society for Microbiology Bicyclomycin Sensitivity and Resistance Affect Rho Factor-Mediated Transcription Termination in the tna Operon of Escherichia coli CHARLES YANOFSKY* AND VIRGINIA HORN Department of Biological Sciences, Stanford University, Stanford, California 94305-5020 Received 13 March 1995/Accepted 27 May 1995 The growth-inhibiting drug bicyclomycin, known to be an inhibitor of Rho factor activity in Escherichia coli, was shown to increase basal level expression of the tryptophanase (tna) operon and to allow growth of a tryptophan auxotroph on indole. The drug also relieved polarity in the trp operon and permitted growth of a trp double nonsense mutant on indole. Nine bicyclomycin-resistant mutants were isolated and partially characterized. Recombination data and genetic and biochemical complementation analyses suggest that five have mutations that affect rho, three have mutations that affect rpoB, and one has a mutation that affects a third locus, near rpoB. Individual mutants showed decreased, normal, or increased basal-level expression of the tna operon. All but one of the resistant mutants displayed greatly increased tna operon expression when grown in the presence of bicyclomycin. The tna operon of the wild-type drug-sensitive parent was also shown to be highly expressed during growth with noninhibitory concentrations of bicyclomycin. These findings demonstrate that resistance to this drug may be acquired by mutations at any one of three loci, two of which appear to be rho and rpoB. Zwiefka et al. (24) found that the antibiotic bicyclomycin segment and interacts with the transcribing RNA polymerase (bicozamycin), an inhibitor of the growth of several gram- molecule, causing it to terminate transcription (7, 9).
    [Show full text]
  • IWS1 Antibody A
    Revision 1 C 0 2 - t IWS1 Antibody a e r o t S Orders: 877-616-CELL (2355) [email protected] Support: 877-678-TECH (8324) 1 8 Web: [email protected] 6 www.cellsignal.com 5 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source: UniProt ID: Entrez-Gene Id: WB, IP, IF-IC H M R Endogenous 140 Rabbit Q96ST2 55677 Product Usage Information Application Dilution Western Blotting 1:1000 Immunoprecipitation 1:50 Immunofluorescence (Immunocytochemistry) 1:200 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity IWS1 Antibody detects endogenous levels of total IWS1 protein. Species Reactivity: Human, Mouse, Rat Source / Purification Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human IWS1 protein. Antibodies are purified by protein A and peptide affinity chromatography. Background Various steps in gene expression, such as mRNA processing, surveillance, export, and synthesis are coupled to transcription elongation (1,2). The C-terminal domain (CTD) of the large subunit of RNA polymerase II plays an important role in the integration of these different steps (1,2). IWS1 interacts with Spt6, a CTD-binding transcription elongation factor and H3 chaperone (1,2). IWS1 also recruits another CTD-binding protein, HYPB/Setd2 histone methyltransferase, to the RNA polymerase II complex for elongation-coupled H3K36 trimethylation (2). Thus, IWS1 links Spt6 and HYPB/Setd2 in a large complex and regulates mRNA synthesis and histone methylation at the co- transcriptional level (2).
    [Show full text]
  • Dynamics of Transcription-Dependent H3k36me3 Marking by the SETD2:IWS1:SPT6 Ternary Complex
    bioRxiv preprint doi: https://doi.org/10.1101/636084; this version posted May 14, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dynamics of transcription-dependent H3K36me3 marking by the SETD2:IWS1:SPT6 ternary complex Katerina Cermakova1, Eric A. Smith1, Vaclav Veverka2, H. Courtney Hodges1,3,4,* 1 Department of Molecular & Cellular Biology, Center for Precision Environmental Health, and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA 2 Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic 3 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA 4 Department of Bioengineering, Rice University, Houston, TX, 77005, USA * Lead contact; Correspondence to: [email protected] Abstract The genome-wide distribution of H3K36me3 is maintained SETD2 contributes to gene expression by marking gene through various mechanisms. In human cells, H3K36 is bodies with H3K36me3, which is thought to assist in the mono- and di-methylated by eight distinct histone concentration of transcription machinery at the small portion methyltransferases; however, the predominant writer of the of the coding genome. Despite extensive genome-wide data trimethyl mark on H3K36 is SETD21,11,12. Interestingly, revealing the precise localization of H3K36me3 over gene SETD2 is a major tumor suppressor in clear cell renal cell bodies, the physical basis for the accumulation, carcinoma13, breast cancer14, bladder cancer15, and acute maintenance, and sharp borders of H3K36me3 over these lymphoblastic leukemias16–18. In these settings, mutations sites remains rudimentary.
    [Show full text]
  • A Master Autoantigen-Ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases Julia Y. Wang1*, Michael W. Roehrl1, Victor B. Roehrl1, and Michael H. Roehrl2* 1 Curandis, New York, USA 2 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA * Correspondence: [email protected] or [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19 pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) displays peculiar affinity to apoptotic cells and autoantigens (autoAgs) and that DS-autoAg complexes cooperatively stimulate autoreactive B1 cell responses, we compiled a database of 751 candidate autoAgs from six human cell types. At least 657 of these have been found to be affected by SARS-CoV-2 infection based on currently available multi-omic COVID data, and at least 400 are confirmed targets of autoantibodies in a wide array of autoimmune diseases and cancer.
    [Show full text]
  • Termination of RNA Polymerase II Transcription by the 5’-3’ Exonuclease Xrn2
    TERMINATION OF RNA POLYMERASE II TRANSCRIPTION BY THE 5’-3’ EXONUCLEASE XRN2 by MICHAEL ANDRES CORTAZAR OSORIO B.S., Universidad del Valle – Colombia, 2011 A thesis submitted to the Faculty of the Graduate School of the University of Colorado in partial fulfillment of the requirements for the degree of Doctor of Philosophy Molecular Biology Program 2018 This thesis for the Doctor of Philosophy degree by Michael Andrés Cortázar Osorio has been approved for the Molecular Biology Program by Mair Churchill, Chair Richard Davis Jay Hesselberth Thomas Blumenthal James Goodrich David Bentley, Advisor Date: Aug 17, 2018 ii Cortázar Osorio, Michael Andrés (Ph.D., Molecular Biology) Termination of RNA polymerase II transcription by the 5’-3’ exonuclease Xrn2 Thesis directed by Professor David L. Bentley ABSTRACT Termination of transcription occurs when RNA polymerase (pol) II dissociates from the DNA template and releases a newly-made mRNA molecule. Interestingly, an active debate fueled by conflicting reports over the last three decades is still open on which of the two main models of termination of RNA polymerase II transcription does in fact operate at 3’ ends of genes. The torpedo model indicates that the 5’-3’ exonuclease Xrn2 targets the nascent transcript for degradation after cleavage at the polyA site and chases pol II for termination. In contrast, the allosteric model asserts that transcription through the polyA signal induces a conformational change of the elongation complex and converts it into a termination-competent complex. In this thesis, I propose a unified allosteric-torpedo mechanism. Consistent with a polyA site-dependent conformational change of the elongation complex, I found that pol II transitions at the polyA site into a mode of slow transcription elongation that is accompanied by loss of Spt5 phosphorylation in the elongation complex.
    [Show full text]
  • 3-End Formation of Baculovirus Late Rnas
    JOURNAL OF VIROLOGY, Oct. 2000, p. 8930–8937 Vol. 74, No. 19 0022-538X/00/$04.00ϩ0 Copyright © 2000, American Society for Microbiology. All Rights Reserved. 3Ј-End Formation of Baculovirus Late RNAs 1 1,2 JIANPING JIN AND LINDA A. GUARINO * Departments of Biochemistry and Biophysics1 and Entomology,2 Texas A&M University, College Station, Texas 77843-2128 Received 13 March 2000/Accepted 30 June 2000 Baculovirus late RNAs are transcribed by a four-subunit RNA polymerase that is virus encoded. The late viral mRNAs are capped and polyadenylated, and we have previously shown that capping is mediated by the LEF-4 subunit of baculovirus RNA polymerase. Here we report studies undertaken to determine the mecha- Downloaded from nism of 3؅-end formation. A globin cleavage/polyadenylation signal, which was previously shown to direct 3؅-end formation of viral RNAs in vivo, was cloned into a baculovirus transcription template. In vitro assays with purified baculovirus RNA polymerase revealed that 3؅ ends were formed not by a cleavage mechanism but rather by termination after transcription of a T-rich region of the globin sequence. Terminated RNAs were released from ternary complexes and were subsequently polyadenylated. Mutational analyses indicated that the T-rich sequence was essential for termination and polyadenylation, but the poly(A) signal and the GT-rich region of the globin polyadenylation/cleavage signal were not required. Termination was not dependent on ATP hydrolysis, indicating a slippage mechanism. http://jvi.asm.org/ mRNA 3Ј-end formation is a complicated process that re- promoters used for overexpression in baculovirus vectors be- quires protein-nucleic acid and protein-protein interactions.
    [Show full text]
  • Regulatory Interplay Between Small Rnas and Transcription Termination Factor Rho Lionello Bossi, Nara Figueroa-Bossi, Philippe Bouloc, Marc Boudvillain
    Regulatory interplay between small RNAs and transcription termination factor Rho Lionello Bossi, Nara Figueroa-Bossi, Philippe Bouloc, Marc Boudvillain To cite this version: Lionello Bossi, Nara Figueroa-Bossi, Philippe Bouloc, Marc Boudvillain. Regulatory interplay be- tween small RNAs and transcription termination factor Rho. Biochimica et Biophysica Acta - Gene Regulatory Mechanisms , Elsevier, 2020, pp.194546. 10.1016/j.bbagrm.2020.194546. hal-02533337 HAL Id: hal-02533337 https://hal.archives-ouvertes.fr/hal-02533337 Submitted on 6 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Regulatory interplay between small RNAs and transcription termination factor Rho Lionello Bossia*, Nara Figueroa-Bossia, Philippe Bouloca and Marc Boudvillainb a Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France b Centre de Biophysique Moléculaire, CNRS UPR4301, rue Charles Sadron, 45071 Orléans cedex 2, France * Corresponding author: [email protected] Highlights Repression
    [Show full text]